Mirum Pharmaceuticals, Inc. (FRA:08D)

Germany · Delayed Price · Currency is EUR

90.50

+5.00 (5.85%)

Last updated: Feb 20, 2026, 5:46 PM CET

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Pharmaceuticals	336.89M	186.37M	77.06M	19.14M	-
Pharmaceuticals Growth	80.76%	141.85%	302.66%	-	-
Total	336.89M	186.37M	77.06M	19.14M	-
Total Growth	80.76%	141.85%	302.66%	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	274.17M	146.70M	67.92M	2.91M	-
United States Growth	86.89%	115.99%	2231.62%	-	-
Rest of the World	62.24M	32.18M	7.14M	225.00K	-
Rest of the World Growth	93.43%	350.50%	3074.22%	-	-
Total	336.41M	178.87M	75.06M	3.14M	-
Total Growth	88.07%	138.30%	2292.03%	-	-

Source: S&P Global Market Intelligence.